近20年妊娠急性脂肪肝患者预后变化和死亡原因分析

doi:10.3969/j.issn.1672-5069.2023.01.015

实用肝脏病杂志 ›› 2023, Vol. 26 ›› Issue (1): 55-58.doi: 10.3969/j.issn.1672-5069.2023.01.015

近20年妊娠急性脂肪肝患者预后变化和死亡原因分析

刘海霞, 朱云霞, 段忠辉, 赖曼, 陈煜

10069 北京市首都医科大学附属北京佑安医院重症医学科(刘海霞,赖曼);产科中心(朱云霞);急诊科(段忠辉);肝病第四中心(陈煜)

收稿日期:2022-04-12 出版日期:2023-01-10 发布日期:2023-02-07
通讯作者: 陈煜,E-mail:chybeyond1071@ccmu.edu.cn
作者简介:刘海霞,女,49岁,医学硕士,副主任医师。主要从事肝病危重症诊治研究。E-mail:lhx52@126.com

Changes of prognosis and causes of death of patients with acute fatty liver of pregnancy in the past two decades

Liu Haixia, Zhu Yunxia, Duan Zhonghui, et al

Department of Critical Care Medicine of Liver Diseases, You'an Hospital, Capital Medical University, Beijing 100069, China

Received:2022-04-12 Online:2023-01-10 Published:2023-02-07

摘要/Abstract

摘要： 目的分析近20年我科诊治的妊娠急性脂肪肝(AFLP)患者的临床特征。方法 2002年1月～2011年12月北京佑安医院收治AFLP患者25例(A组),2012年1月～2022年1月收治28例(B组),对比分析两组临床表现、并发症、病死率变化和死亡原因。结果 A组和B组血清总胆红素水平分别为 (239.8±104.2)μmol/l和【(161.9±107.7)μmol/l, P=0.052】, A组肝功能异常率为12.0%,显著低于B组的42.9%(P=0.006);A组剖宫产率为76.0%,显著低于B组的100.0%(P=0.020);A组与B组DIC(40.0%对3.6%,P=0.001)和失血性休克发生率(24.0%和3.6%,P=0.028)存在显著性差异,而产后出血(48.0%对25.0%,P=0.081)无显著性差异;B组产妇病死率为3.6%而胎儿无死亡,显著低于A组的24.0%和12.1%(P<0.05)。结论 DIC和大出血是10年前AFLP产妇的主要死亡原因,近10年AFLP母婴病死率明显下降,但肝衰竭进展仍较常见,仍需早期识别和处理。

关键词: 妊娠急性脂肪肝, 产后出血, 弥散性血管内凝血, 肝衰竭, 病死率

Abstract: Objective The prognosis of patients with acute fatty liver of pregnancy (AFLP) have dramatically improved, and the main purpose of this study was to summarize the clinical feature shift of the entity in the past two decades. Method The clinical data of patients with AFLP in Beijing You'an Hospital were retrospectively analyzed, and 25 patients in group A were encountered in this hospital between January 2002 and December 2011, and other 28 patients in group B were from January 2012 to January 2022. The clinical manifestations, complications and mortalities in the two groups were compared, and the causes of death were analyzed. Results There was no significant difference respect to serum bilirubin levels in the two groups [(239.8±104.2)μmol/l vs. (161.9±107.7 )μmol/l, P=0.052], while the incidence of abnormal liver function tests in group A was 12.0%, significantly lower than 42.9%(P=0.006) in group B, the cesarean section in group A was 76.0%, much lower than 100.0%(P=0.020) in group B, the incidences of disseminated intravascular coagulation (DIC, 40.0% vs. 3.6%, P=0.001) and the hemorrhagic shock (24.0% vs. 3.6%, P=0.028) were significantly different; the maternal fatality in group B was 3.6%, much lower than 24.0% in group A. Conclusion The leading causes of maternal death in patients with AFLP ten years ago were DIC and massive hemorrhage, while the liver failure is common in recent ten years although the mortality falls dramatically, and the early diagnosis and management is still important.

Key words: Acute fatty liver of pregnancy, Postpartum hemorrhag, Disseminated intravascular coagulation, Liver failure, Mortality

刘海霞, 朱云霞, 段忠辉, 赖曼, 陈煜. 近20年妊娠急性脂肪肝患者预后变化和死亡原因分析[J]. 实用肝脏病杂志, 2023, 26(1): 55-58.

Liu Haixia, Zhu Yunxia, Duan Zhonghui, et al. Changes of prognosis and causes of death of patients with acute fatty liver of pregnancy in the past two decades[J]. Journal of Practical Hepatology, 2023, 26(1): 55-58.

参考文献

[1] Liu J, Ghaziani TT, Wolf JL. Acute fatty liver disease of pregnancy: Updates in pathogenesis, diagnosis, and management. Am J Gastroenterol,2017, 112(6):838-846.
[2] Ramanathan R, Ibdah JA. Mitochondrial dysfunction and acute fatty liver of pregnancy. Int J Mol Sci,2022, 23(7):3595.
[3] Rolfes DB, Ishak KG. Acute fatty liver of pregnancy: A clinicopathologic study of 35 cases. Hepatology,1985, 5(6):1149-1158.
[4] Knight M, Nelson-Piercy C,Kurinczuk JJ, et al. UK obstetric surveillance system: A prospective national study of acute fatty liver of pregnancy in the UK. Gut,2008, 57(7):951-967.
[5] Fesenmeier MF, Coppage KH, Lambers DS, et al. Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol,2005, 192(5):1416-1419.
[6] Gao Q, Qu X, Chen X, et al. Outcomes and risk factors of patients with acute fatty liver of pregnancy: a multicentre retrospective study. Singapore Med J, 2018, 59(8):425-430.
[7] Ch'ng CL, Morgan M, Hainsworth I, et al. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut,2002, 51(6):876-880.
[8] 中华医学会感染病学分会肝衰竭与人工肝学组;中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版).实用肝脏病杂志,2019,22(2):164-171.
[9] Mehta RL,Kellum JA, Shah SV, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care,2007, 11(2): R31.
[10] Reyes H, Sandoval L, Wain stein A, et al. Acute fatty of pregnancy a clinical study of 12 episodes in 11 patient. Gut,1994, 35:101-106 .
[11] Goel A, Ramakrishna B, Zachariah U, et al. How accurate are the Swansea criteria to diagnose acute fatty liver of pregnancy in predicting hepatic microvesicularsteatosis? Gut,2011, 60(1):138-139.
[12] Naoum EE, Leffert LR, Chitilian HV, et al. Acute fatty liver of pregnancy: pathophysiology, anesthetic implications, and obstetrical management. Anesthesiology,2019,130(3):446-461.
[13] Goel A, Eapen CE, Mathews J, et al. Acute fatty liver of pregnancy: better understanding of pathogenesis and earlier clinical recognition results in improved maternal outcomes. EMJ Hepatol, 2018, 69(1):72-79.
[14] Vigil-deGracia P, Montufar-Rueda C. Acute fatty liver of pregnancy: diagnosis, treatment, and outcome based on 35 consecutive cases. J Matern Fetal Neonatal Med, 2011, 24(9):1143-1146.
[15] Goel A, Nair SC, Viswabandya A, et al. Preliminary experience with use of recombinant activated factor VII to control postpartum hemorrhage in acute fatty liver of pregnancy and other pregnancy-related liver disorders. Indian J Gastroenterol,2013, 32(4):268-271.
[16] Baju N M, Henry N, Innah S J. Management of coagulopathy in acute fatty liver of pregnancy. J Case Rep,2016, 6:317-320.
[17] Nelson DB, Yost NP, Cunningham FG. Acute fatty liver of pregnancy: clinical outcomes and expected duration of recovery. Am J Obstet Gynecol,2013, 209:456e1-7.
[18] Bernal W,Hyyrylainen A, Gera A, et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol,2013, 59(1):74-80.
[19] Tang W, Huang Z, Wang Y, et al. Effect of plasma exchange on hepatocyte oxidative stress, mitochondria function, and apoptosis in patients with acute fatty liver of pregnancy. Artif Organs,2012, 36(3): E39-47.
[20] Kushner T, Tholey D, Dodge J, et al. Outcomes of liver transplantation for acute fatty liver disease of pregnancy. Am J Transplant, 2019,19(7):2101-2107.

近20年妊娠急性脂肪肝患者预后变化和死亡原因分析

Changes of prognosis and causes of death of patients with acute fatty liver of pregnancy in the past two decades

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	吴成勇, 陈冲, 刘文艳, 唐光敏. 慢加急性乙型肝炎肝衰竭患者并发细菌感染及其预测模型效能评价^*[J]. 实用肝脏病杂志, 2023, 26(1): 59-62.
[2]	邵思萌, 高峰, 蒋磊, 魏亚虎, 赵威. 慢加急性乙型肝炎肝衰竭患者外周血巨噬细胞极化和TXNIP/NLRP3水平与预后的关系探讨^*[J]. 实用肝脏病杂志, 2023, 26(1): 63-66.
[3]	祝欣雯, 王卫兵, 袁福兵, 吴鑫. NLR联合血清IL-6水平预测慢加急性乙型肝炎肝衰竭患者近期预后的价值探讨^*[J]. 实用肝脏病杂志, 2023, 26(1): 67-70.
[4]	贺锦帆, 姚佳, 赵强, 王娟, 白津佳, 赵凝慧. 双重血浆分子吸附系统治疗肝衰竭患者发生血管迷走神经反应相关因素分析及其处理对策研究^*[J]. 实用肝脏病杂志, 2022, 25(6): 828-831.
[5]	李荣, 曹晶晶, 李晶, 潘峰. 慢加急性/亚急性乙型肝炎肝衰竭患者发病诱因及影响临床转归因素分析^*[J]. 实用肝脏病杂志, 2022, 25(6): 832-835.
[6]	王明强, 牛垚飞, 王生锋. 慢加急性乙型肝炎肝衰竭患者血清聚集素水平变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2022, 25(5): 677-680.
[7]	沈扬林, 谭可平, 游忠岚, 陈婵, 陆晖, 甘琼萍, 覃国琦, 陆鹏. 血浆置换序贯双重血浆分子吸附系统治疗慢加急性乙型肝炎肝衰竭患者疗效研究^*[J]. 实用肝脏病杂志, 2022, 25(3): 387-390.
[8]	孙亚男, 曾庆环, 刘远志, 张世斌, 李鹏, 武永乐, 丁惠国. 伴有中/重度食管静脉曲张的慢加急性肝衰竭患者预后危险因素分析^*[J]. 实用肝脏病杂志, 2022, 25(3): 391-394.
[9]	张剑, 陈煜, 段钟平. HBV-ACLF患者血清FT3水平变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2022, 25(2): 239-242.
[10]	汪娅, 罗婷婷, 李璨, 赵文静, 陆爽. 曲美他嗪对急性肝衰竭小鼠肝组织NOX2和NOX4表达的影响[J]. 实用肝脏病杂志, 2021, 24(6): 799-802.
[11]	刘积庆, 于国英, 杨生森, 黄群, 保成兰. 多种预后评分系统预测慢加急性肝衰竭并发真菌感染患者短期预后价值分析^*[J]. 实用肝脏病杂志, 2021, 24(6): 851-854.
[12]	董金玲, 李璐, 陈煜. 缓慢持续型慢加急性肝衰竭与慢性肝衰竭的甄别^*[J]. 实用肝脏病杂志, 2021, 24(5): 611-612.
[13]	陈丹丹, 龙志达, 黄顺东, 王文虎, 尹明红, 李忠斌. 慢加急性乙型肝炎肝衰竭患者发生感染和急性肾损伤危险因素分析^*[J]. 实用肝脏病杂志, 2021, 24(5): 717-720.
[14]	黄霜湘, 姚朝光, 蓝婧, 欧琴, 覃冬林, 陈丽芬, 黄洁婕. 慢加急性乙型肝炎肝衰竭患者血清自噬相关蛋白水平及其临床意义探讨^*[J]. 实用肝脏病杂志, 2021, 24(5): 721-724.
[15]	鲁小龙, 解春宝. IL-6基因多态性对HBV相关ACLF患者短期预后的影响[J]. 实用肝脏病杂志, 2021, 24(4): 516-519.